Turn Therapeutics Inc

Research Turn Therapeutics Inc (TTRX) on Bullrun: market cap USD 289.84M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 289.84M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025n/a-USD 3.19Mn/an/a-0.12USD 4.03MUSD 101.45KUSD 4.69M
FY2024n/a-USD 1.77Mn/an/a-0.07USD 498.29Kn/a-USD 177.43K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 289.84Mn/an/an/a
20252025-12-31USD 116.01Mn/an/an/a

About Turn Therapeutics Inc

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Turn Therapeutics Inc's market cap?

Turn Therapeutics Inc's market capitalization is USD 289.84M.

What does Turn Therapeutics Inc do?

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc.